Elimination of Parent-to-Child Transmission Publications
In April 2020, new directions in global guidance for HIV strategic information and treatment monitoring were updated. This technical update outlines the key developments with respect to recommended indicators and approaches and tools for monitoring antiretroviral drug toxicity with the purpose of strengthening country implementation and ensuring the safe use of antiretroviral drugs.
This governance guidance provides further detail on the standardized structure and processes used to validate the elimination of the mother-to-child transmission (EMTCT) of HIV and syphilis. This publication serves alongside and as a supplement to the Global guidance on the criteria and processes for validation: elimination of mother-to-child transmission of HIV and syphilis (global EMTCT guidance), the four country assessment tools on EMTCT of HIV and syphilis and the pre-assessment tool on EMTCT of HIV and syphilis and termed path to elimination (PTE).
Over the last three decades, scientific findings from a range of disciplines have converged. They prove that in the early years, we lay down critical elements for health, well-being and productivity, which last throughout childhood, adolescence and adulthood. Failure to meet a child’s needs during this critical period limits the child’s ability to achieve their full developmental potential and threatens the future of human capital and society in general.
WHO estimates that in 2015, 257 million people were living with chronic hepatitis B virus (HBV) infection worldwide, and that 900 000 had died from HBV infection, mostly as a result of cirrhosis or hepatocellular carcinoma. Most HBV-associated deaths among adults are secondary to infections acquired at birth or in the first five years of life.
A side event was held at the 2019 conference for the replenishment of the Global Fund to Fight AIDS, Tuberculosis and Malaria in October 2019 to consider the effective use of global health resources. The meeting underscored the potential public health impact of expanding viral hepatitis elimination programming through strategic integration, including integration with existing efforts to eliminate AIDS and TB.